IMEPRINT-Incorporation of Microencapsulated Enzymes into screen PRINTed carbon graphite inks

imeprint——将微封装酶纳入丝网印刷碳石墨墨水，旨在评估微封装酶和介质在水性碳墨水中的可行性。如果成功，该系统将通过丝网印刷用于构建生物传感器。酶的微胶囊化可以提高酶在打印过程中的稳定性，增强酶的稳定性，减少构建生物传感器的打印步骤。因此，该项目涵盖了TSB配方产品呼吁中规定的三个技术领域的范围，即交付配方、稳定性配方和可持续性配方。这种微胶囊技术的新应用将把成分精确地输送到生物传感器上的一个非常特定的区域。它将提高所封装的所有成分的稳定性，并以水性环保型丝网印刷油墨取代溶剂型丝网印刷油墨。这种新型墨水的使用将大大节省生产糖尿病试纸和其他丝网印刷生物传感器的劳动力成本、运营成本和原材料成本。

IMEPRINT-Incorporation of Microencapsulated Enzymes into screen PRINTed carbon graphite inks, aims to assess the feasibility of microencapsulating enzymes and mediators for inclusion in a water based carbon ink. If successful this system will be used to construct biosensors by screen printing. The microencapsulation of enzymes should lead to improved stability of enzymes during the printing process, enhanced enzyme stability and a reduction in the number of printing steps to construct the biosensor. The project thus covers the scope of three technology areas specified in the TSB Formulated Products call, namely formulation for delivery, formulation for stability and formulation for sustainability. This novel application of microencapsulation technology will deliver ingredients precisely to a very specific area on a biosensor. It will improve the stability of all the ingredients encapsulated and replace a solvent based screen printing ink with a water based environmentally friendly one. The use of this novel ink will lead to dramatic savings in labour costs, operating costs and raw material costs for the oroduction of diabetic test strips and other screen printed biosenors.